Omeros reported $712K in Stock for its fiscal quarter ending in September of 2021.





Stock Change Date
Adma Biologics USD 206.46M 9.8M Dec/2025
Alnylam Pharmaceuticals USD 200.15M 117.43M Mar/2026
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Cytokinetics USD 0 0 Dec/2023
Gilead Sciences USD 1.77B 11M Dec/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 132.07M 11.1M Dec/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
MacroGenics USD 7.91M 840K Dec/2025
Omeros USD 712K 266K Sep/2021
Pacira USD 150.37M 2.49M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Rockwell Medical USD 4.16M 885K Jun/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
United Therapeutics USD 183.1M 6.6M Dec/2025
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026